Although both elevated PRL levels and E2 supplementation are associated with increased mammographic density [66, 67], the effect of these changes in the ECM on the actions of these hormones in ERα+ breast cancer is poorly understood. This evidence concerns the gene ESR1 and breast carcinoma.